English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12500/13673 (91%)
造訪人次 : 2598196      線上人數 : 387
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    主頁登入上傳說明關於NHRI管理 到手機版
    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/15445


    題名: Fine-mapping across diverse ancestries drives the discovery of putative causal variants underlying human complex traits and diseases
    作者: Yuan, K;Longchamps, R;Pardiñas, A;Yu, MR;Chen, TT;Lin, SC;Chen, Y;Lam, M;Daly, M;Neale, B;Lin YF;Chen, CY;O'Donovan, M;Ge, T;Huang, HL
    貢獻者: Center for Neuropsychiatric Research
    摘要: Genome-wide association studies (GWAS) of human complex traits or diseases often implicate genetic loci that span hundreds or thousands of genetic variants, many of which have similar statistical significance. These loci may contain one or a handful of causal variants, while the associations of other variants are driven by their linkage disequilibrium (LD) with the causal variant(s). Statistical fine-mapping refines a GWAS locus to a smaller set of likely causal variants (i.e., credible set) to facilitate interpretation and prioritize laboratory-based functional studies. Fine-mapping studies in samples of European ancestry have made important advances, with some disease-associated loci resolved to single-variant resolution. Since non-causal variants tagging causal signals have marginally different effects across populations where LD differs, capitalizing on the genomic diversity across ancestries holds the promise to further improve the resolution of fine-mapping. However, to date, cross-population fine-mapping efforts have been limited, partly due to the lack of statistical methods that can appropriately integrate data from multiple ancestries. Building on the Sum of Single Effects (SuSiE), a single-population fine-mapping model, we have developed SuSiEx, an accurate and computationally efficient method for trans-ancestry fine-mapping. Our model can integrate data from an arbitrary number of ancestries, explicitly models population-specific LD patterns, and accounts for multiple causal variants in a genomic region. Our simulation studies revealed that SuSiEx outperformed single-population fine-mapping methods in terms of power, resolution, and scalability. Additionally, we conducted a comparison of SuSiEx with two published Bayesian cross-population fine-mapping methods, PAINTOR and MsCAVIAR. The results clearly demonstrate that SuSiEx is more efficient, user-friendly, high-power, and well-calibrated. Encouraged by simulation results, we applied SuSiEx to data from the Pan-UKBB project and the Taiwan Biobank (TWB). We included summary statistics of EUR and AFR (NEU = 419,807; NAFR = 6,570) ancestries from Pan-UKBB. We additionally included TWB, one of the largest biomedical databases in East Asia (NEAS = 92,615). We selected 25 quantitative traits shared between Pan-UKBB and TWB and defined 13,420 candidate loci. In the biobank analysis, by using SuSiEx, the power, and resolution were Improved. We applied SuSiEx to schizophrenia GWAS summary statistics of EUR (Ncase = 53,251, Ncontrol = 77,127) and EAS (Ncase = 14,004, Ncontrol = 16,757) ancestries from the Psychiatric Genomics Consortium (PGC), and fine-mapped the same 250 autosomal loci in the recent PGC publication4. SuSiEx successfully identified 215 credible sets out of 193 loci, among which 11 had a SNP with PIP >95%. As expected, SuSiEx outperformed published PGC fine-mapping results, which applied a single-population fine-mapping method, FINEMAP, to meta-analyzed GWAS summary statistics and sample size weighted LD. Specifically, SuSiEx mapped 57% (33 vs. 21) more signals to a single variant with PIP >50% in single-credible-set loci. Furthermore, SuSiEx substantially increased the resolution of fine-mapping by reducing the average size of credible sets from 87.1 to 60.3 (P = 0.015; paired two-sided t-test), and increasing the average of maximum PIP across credible sets from 0.25 to 0.27 (P = 0.012; paired two-sided t-test).
    日期: 2023-10
    關聯: European Neuropsychopharmacology. 2023 Oct;75(Suppl. 1):S6-S7.
    Link to: http://dx.doi.org/10.1016/j.euroneuro.2023.08.021
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0924-977X&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:001089437400021
    顯示於類別:[林彥鋒] 會議論文/會議摘要

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    ISI001089437400021.pdf89KbAdobe PDF103檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋